Skip to main content
. Author manuscript; available in PMC: 2019 Feb 20.
Published in final edited form as: Heart. 2018 May 15;104(20):1647–1653. doi: 10.1136/heartjnl-2017-312123

Table 2.

Angiographic findings in symptomatic and asymptomatic patients with a history of mediastinal malignancies treated with high-dose radiation exposure

Coronary angiography
(% of cases with the specified disease severity)
Study,
design
N Mean study
interval, years
Mean/
median
age, years*
Radiation
exposure, Gy
(mean)
≥70% of LAD, LCx, or RCA:
Ostial
vessel
≥50%
LM≥50% LM≥70%
1- v 2- v 3- v
Orzan et al, 199310 retrospective, observational Symptomatic 24 HL/BCA survivors 15 for CAG 12 44 >45 40 20 13 67% 47% 43%
McEniery et al, 19879 retrospective, case–control 15 HL/BCA survivors 15 for CAG 16 48 41 53 20 7 27% 33% 20%
Correa et al, 200746 retrospective, case–control 46 BCA survivors 13 for CAG 15 55 60–65 31 23 0 NA NA NA
Heidenreich et al, 200713 prospective, observational Asymptomatic 294 HL survivors 40 for CAG 6.5 42 44 10 10 NA >28% NA 50%
Rademaker et al, 200847 retrospective, case series 9 HL survivors 9 for CCTA 26 45 40 33 0 0 0 9% 9%
Daniels et al, 201448 prospective, observational 48 HL survivors for CCTA 8 for CAG 21 47 36 33 0 0 33% 0 22%
*

Denotes age at time of angiography.

Reported as ‘chest’ or ‘mediastinal dose’; elsewhere, mean heart doses are reported.

Reported as left main≥70% or three-vessel disease with at least one vessel with ≥70% stenosis.

BCA, breast cancer; CAG, coronary angiography; CCTA, coronary CT angiography; LAD, left anterior descending; LCx, left circumflex coronary artery; LM, left main; NA, not available; RCA, right coronary artery.